Press Releases

5 Nov. 2020

PainReform Welcomes Senior Pharmaceutical Executive and Venture Capitalist Augustine Lawlor to Board of Directors
19 Oct. 2020

PainReform Highlights Surgical Advantages of PRF-110
29 Sep. 2020

PainReform Commences Preparations for Pivotal Phase 3 Clinical Trials
10 Sep. 2020

PainReform Announces Closing of $20.0 Million Initial Public Offering
8 Sep. 2020

PainReform Announces Pricing of $20.0 Million Initial Public Offering

Send a Message

Font Resize

Contrast